histone modifying enzymes) may shed light on the late stages in the evolution of cancer cells during tumorigenesis, and suggest ways of controlling these processes through the manipulation of these shared, evolved mechanisms.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for nonommercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals. and cellular proliferation remain ill-defined. Furthermore, the language of evolution is often employed in carcinogenesis without full explanation. For example, a typical description of carcinogenesis proposes that random mutations 'confer a selective growth advantage' resulting in clonal expansion and subsequent tumor growth. However, precisely how a genomic change alters the phenotype and how a phenotypic trait interacts with environmental growth constraints and selection factors to promote proliferation remains vague. Many interesting and important controversies remain unresolved within the Darwinian model of carcinogenesis. For example, tumor evolution is often portrayed as a linear sequence of genomic mutations and epigenetic changes synchronous with progressive drift of cellular populations from normal through premalignant lesions to invasive cancer. 6 This approach, however, while useful conceptually and pedagogically, is highly simplified ignoring, for example, the stochastic nature of mutations, mitigating intracellular processes such as the chaperone function of heat shock proteins, and extracellular factors such as the potential influence of microenvironmental selection factors.
Similarly, the role of the mutator phenotype remains unclear. Loeb and others 7 hypothesize an increased mutation rate due to defects in chromosomal stability or DNA repair pathways is necessary as a forcing function to produce the number of genomic changes required for evolution of invasive cancer. This assumes the background mutation rate is insufficient to allow the necessary carcinogenic mutations to accumulate in the human life-span. The role of the mutator phenotype is supported by observation of large numbers of mutations in most cancer cells 8 and increased mutation rates in early colon and esophageal cancers. 9, 10 However, the mutator hypothesis has been criticized as 'cellcentric' and incomplete. Tomlinson, Rubin, and others cite 11, 12 empirical evidence and mathematical models to demonstrate normal mutation rates are sufficient for tumor evolution in microenvironments generating strong clonal selection. Furthermore, Bissell and co-workers [13] [14] [15] [16] have published a number of studies showing microenvironmental factors such as the extracellular matrix (ECM) and admixed normal cell populations alter tumor cell proliferation independent of permanent genomic change. In fact, they find, in some stages of somatic evolution, the environment plays a greater role than mutagenesis. Finally, the mutator hypothesis does not typically incorporate epigenetic phenomenon such as DNA methylation and acetylation or intracellular factors such as heat shock proteins that can maintain phenotypic robustness in the face of genomic heterogeneity. Thus, while the conceptual model of cancer as somatic evolution is appealing and well accepted, we are far from understanding the actual dynamics governing the Darwinian interactions of altered cellular genotypes with phenotypic expression and environmental selection forces. In large part, these limitations reflect an absence of quantitative models to serve as frameworks of understanding to organize extant data, integrate new information, and stimulate new empirical studies. Indeed, it seems clear that carcinogenesis is governed by complex, non-linear processes and, for this reason, the multi step, multiyear, multipath transformation of normal cells to invasive cancer will not be understood fully without development of appropriate biologically informed quantitative models. 17, 18 In this issue Vineis 
